No Data
No Data
Tharimmune Announce Preclinical TH023 Results
12 Health Care Stocks Moving In Monday's Pre-Market Session
Express News | Tharimmune: Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-Alpha
Tharimmune Announces Expansion of Product Pipeline With HS1940
Express News | Tharimmune Expanded Its Product Pipeline With HS1940, A Dual-target Multispecific Biologic Engineered To Bind To Both Programmed Death-1 And Vascular Endothelial Growth Factor Receptors
Express News | Tharimmune Inc - Thomas Hess Resigns as CFO of Tharimmune Effective March 26, 2025
Yubraj : @Jaguar8 brother how about TNON
Yubraj Yubraj : is it in your radar or not?
Jaguar8 OP Yubraj : Yes it is but it will be on stocks with news which i will post later. Still reviewing others stocks with news. It will be included for sure
Yubraj Jaguar8 OP : thank you
72149607 : what u think about VVPR jag bro pre market today?
View more comments...